 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Affy Sees Opportunities for New 384-Sample Axiom Genotyping Product in Ag, Disease Research Markets
January 22, 2013
Affy Sees Opportunities for New 384-Sample Axiom Genotyping Product in Ag, Disease Research Markets
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Affymetrix's eBio Business Moving FlowCytomix Assays to Luminex Platform, Planning New Product Combinations
April 2, 2013 / BioArray News - Affy Files CytoScan with FDA, Plans 'Aggressive' Marketing Campaign to Grow Cyto Business
February 19, 2013 / BioArray News - After 'Pivotal' 2012, Affy Looks to CytoScan, Axiom Genotyping Products to Drive Future Growth
February 5, 2013 / BioArray News - People in the News: Richard Shippy, Lisa Shaffer, Michel Bouchard
December 18, 2012 / BioArray News - Atlas Biolabs Accredited as CSP for Affymetrix's DMET Plus
September 25, 2012 / GenomeWeb Daily News